0001891596-22-000002.txt : 20220516 0001891596-22-000002.hdr.sgml : 20220516 20220516153744 ACCESSION NUMBER: 0001891596-22-000002 CONFORMED SUBMISSION TYPE: 13F-NT PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220331 FILED AS OF DATE: 20220516 DATE AS OF CHANGE: 20220516 EFFECTIVENESS DATE: 20220516 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Sphera Healthcare US Inc. CENTRAL INDEX KEY: 0001891596 IRS NUMBER: 421778246 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 13F-NT SEC ACT: 1934 Act SEC FILE NUMBER: 028-21415 FILM NUMBER: 22928200 BUSINESS ADDRESS: STREET 1: 10 EAST 53RD STREET SUITE 1301 CITY: NEW YORK CITY STATE: NY ZIP: 10022 BUSINESS PHONE: 212-554-4457 MAIL ADDRESS: STREET 1: 10 EAST 53RD STREET SUITE 1301 CITY: NEW YORK CITY STATE: NY ZIP: 10022 13F-NT 1 primary_doc.xml 13F-NT LIVE false false false 0001891596 XXXXXXXX 03-31-2022 03-31-2022 Sphera Healthcare US Inc.

10 EAST 53RD STREET SUITE 1301 NEW YORK CITY NY 10022

13F NOTICE 028-21415 0001496201 028-15863 SPHERA FUNDS MANAGEMENT LTD. Y Investment discretion with regard to a portion of the securities reported herein is exercised by Sphera Healthcare US Inc (the "Management Company"). The Management Company is wholly owned by Sphera Global Healthcare Management L.P. ("SGHM") which is managed, controlled, and operated by its general partner, Sphera Global Healthcare GP Ltd. (the "General Partner"), the shares of which are owned 90% by Sphera Funds Management Ltd. ("SFML"). SFML is entitled to appoint the members of the board of directors of the General Partner (the "Board of Directors"), and therefore may be deemed to control the General Partner and the Management Company. This Form 13F shall not be construed as an admission by SFML, SGHM, the General Partner, or the Management Company that it is the beneficial owner of any of the securities covered by this Form 13F, and each of SFML, the General Partner, SGHM, and the Management Company disclaim beneficial ownership of any such securities. Per informal guidance received from the Division of Investment Management, section 13(f) securities that are dual listed on a U.S. stock exchange and the Tel Aviv Stock Exchange were included in this Form 13F only if they were purchased in the U.S. Steven Dorfman 646-699-8282 Steven Dorfman New York NY 05-16-2022